We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
-16.07%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.14B
AUM Growth
-$212M
Cap. Flow
+$98.4M
Cap. Flow %
8.63%
Top 10 Hldgs %
46.56%
Holding
206
New
51
Increased
51
Reduced
18
Closed
36
Avg Time Held Equity + Options
3 quarters
Top 10 Avg Time Held Equity + Options
4.1 quarters
Top 20 Avg Time Held Equity + Options
4.2 quarters
Avg Time Held Equity only
3.1 quarters
Top 10 Avg Time Held Equity only
4.1 quarters
Top 20 Avg Time Held Equity only
4.3 quarters

Top Buys

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.8M
2
HUM icon
Humana
HUM
+$19.1M
3
XLRN
Acceleron Pharma
XLRN
+$15.3M
4
QTNT
Quotient Limited Ordinary Shares
QTNT
+$13.2M
5
MDVN
MEDIVATION, INC.
MDVN
+$12.3M

Top Sells

Rank Stock Value
1
DYAX
DYAX CORPORATION
DYAX
+$68.4M
2
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$12.9M
3
BAX icon
Baxter International
BAX
+$10.1M
4
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
+$8.54M
5
NVRO icon
NEVRO CORP.
NVRO
+$8M

Sector Composition

Rank Sector Weight
1 Healthcare 92.87%
2 Miscellaneous 6.35%
3 Consumer Staples 0.6%
4 Consumer Discretionary 0.11%
5 Industrials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ITGR icon
176
Integer Holdings
ITGR
$4.3B
– –
-4,817
Closed -$231K –
LNTH icon
177
Lantheus
LNTH
$6.53B
– –
-38,784
Closed -$131K –
SAGE icon
178
DELISTED
Sage Therapeutics
SAGE
– –
-20,000
Closed -$1.17M –
SRPT icon
179
PUT
Sarepta Therapeutics
SRPT
$1.74B
– –
-100,000
Closed -$3.86M –
THC icon
180
Tenet Healthcare
THC
$21.5B
– –
-6,927
Closed -$210K –
TTNP icon
181
DELISTED
Titan Pharmaceuticals
TTNP
– –
-145
Closed -$1.94M –
UTMD icon
182
Utah Medical Products
UTMD
$237M
– –
-1,828
Closed -$107K –
ASXC icon
183
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-131,995
Closed -$4.26M –
HEWG icon
184
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
– –
-100,000
Closed -$2.44M –
AVGR icon
185
DELISTED
Avinger, Inc. Common Stock
AVGR
– –
0
– -$444K
2016 Q1
0 quarters
ACGN
186
DELISTED
Aceragen Inc
ACGN
– –
-34
Closed -$14K –
BLCM
187
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
– –
-42,119
Closed -$8.54M –
LHCG
188
DELISTED
LHC Group LLC
LHCG
– –
-3,705
Closed -$168K –
LCI
189
DELISTED
Lannett Company, Inc.
LCI
– –
-1,046
Closed -$168K –
GWPH
190
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-400,000
Closed -$27.8M –
MDCO
191
DELISTED
Medicines Co
MDCO
– –
-75,000
Closed -$2.8M –
CBM
192
DELISTED
Cambrex Corporation
CBM
– –
-4,692
Closed -$221K –
EXAC
193
DELISTED
Exactech Inc
EXAC
– –
-10,734
Closed -$195K –
SCAI
194
DELISTED
Surgical Care Affiliates, Inc.
SCAI
– –
-5,133
Closed -$204K –
ARIA
195
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-50,000
Closed -$313K –
AMSG
196
DELISTED
Amsurg Corp
AMSG
– –
-2,243
Closed -$170K –
VTAE
197
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– –
-200,000
Closed -$3.62M –
HNT
198
DELISTED
HEALTH NET INC
HNT
– –
-3,831
Closed -$262K –
DYAX
199
DELISTED
DYAX CORPORATION
DYAX
– –
-1,819,215
Closed -$68.4M –
LPNT
200
DELISTED
LifePoint Health, Inc.
LPNT
– –
-2,862
Closed -$210K –
5 6 7
8
9

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Perceptive Advisors held 206 positions worth $1.14B, down 16% from $1.35B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $98.4M of net new capital in Q1 2016, opening 51 new positions and adding to 51 existing holdings. Its largest new stake was Humana: 110,000 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 89% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Teva Pharmaceutical Industries Limited, an estimated $12.9M trimmed.

  • Perceptive Advisors's largest Q1 2016 buy was Humana: 110,000 shares worth $20.1M.
  • Perceptive Advisors added most to Sarepta Therapeutics in Q1 2016, an estimated $27.8M increase.
  • Perceptive Advisors's biggest Q1 2016 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $12.9M.
  • Perceptive Advisors fully exited DYAX CORPORATION in Q1 2016, selling an estimated $68.4M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $1.14B portfolio in Q1 2016.
  • Perceptive Advisors opened 51 new positions and closed 36 in Q1 2016.
  • Perceptive Advisors's portfolio value fell 16% quarter-over-quarter to $1.14B.

Based on Perceptive Advisors's 13F filing for Q1 2016, filed 16 May 2016.